文献速递瓣膜病与结构性心脏病

定向诱导人诱导多能干细胞分化为心脏瓣膜细胞

Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells.
PubMed 文献 · Circulation · 2024-02-15

研究建立了一种高效诱导人诱导多能干细胞(hiPSCs)分化为功能性瓣膜内皮样细胞和间质样细胞的方案,通过序贯激活Wnt、BMP4、VEGF和NFATc1信号通路,分化6天及CD144磁珠分选后获得约70% CD144+细胞和30% CD144-细胞。单细胞RNA测序揭示分化轨迹与胚胎瓣膜发育一致,并鉴定关键开关基因、信号通路和转录因子。

要点

  • 序贯激活Wnt、BMP4、VEGF和NFATc1信号通路可高效诱导hiPSCs分化为瓣膜内皮样和间质样细胞。
  • 分化6天及CD144分选后获得约70% CD144+细胞和30% CD144-细胞,基因表达与功能类似原代瓣膜细胞。
  • 单细胞RNA测序揭示分化轨迹与胚胎瓣膜发育一致,瓣膜间质样细胞可能源于内皮样细胞经内皮间质转化。

核心结论

  • 首次报道了从hiPSCs高效生成功能性瓣膜内皮样细胞和间质样细胞的策略,并阐明了分化轨迹和转录动态。

研究设计与样本

  • 研究使用hiPSCs,序贯激活Wnt、BMP4、VEGF和NFATc1信号通路进行定向分化,并通过纵向单细胞RNA测序分析分化轨迹。

主要发现

  • 分化6天及CD144磁珠分选后获得约70% CD144+细胞和30% CD144-细胞。
  • CD144+细胞基因表达谱与原代瓣膜内皮细胞高度相似,并具有成管、摄取低密度脂蛋白、生成内皮型一氧化氮合酶及响应剪切力的功能。
  • CD144-细胞可分泌胶原和基质金属蛋白酶,并像原代瓣膜间质细胞一样向成骨或成脂谱系分化。
  • 分化轨迹与胚胎瓣膜发育一致,鉴定出主要开关基因NOTCH1、HEY1和MEF2C,信号通路TGF-β、Wnt和NOTCH,以及转录因子MSX1、SP5和MECOM。
  • hiPSC来源的瓣膜间质样细胞可能源于hiPSC来源的瓣膜内皮样细胞经内皮间质转化。

临床怎么用

  • 该方案可为瓣膜疾病研究提供高质量均一的功能性心脏瓣膜细胞来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A main obstacle in current valvular heart disease research is the lack of high-quality homogeneous functional heart valve cells. Human induced pluripotent stem cells (hiPSCs)-derived heart valve cells may help with this dilemma. However, there are no well-established protocols to induce hiPSCs to differentiate into functional heart valve cells, and the networks that mediate the differentiation have not been fully elucidated. METHODS: To generate heart valve cells from hiPSCs, we sequentially activated the Wnt, BMP4, VEGF (vascular endothelial growth factor), and NFATc1 signaling pathways using CHIR-99021, BMP4, VEGF-165, and forskolin, respectively. The transcriptional and functional similarity of hiPSC-derived heart valve cells compared with primary heart valve cells were characterized. Longitudinal single-cell RNA sequencing was used to uncover the trajectory, switch genes, pathways, and transcription factors of the differentiation. RESULTS: An efficient protocol was developed to induce hiPSCs to differentiate into functional hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells. After 6-day differentiation and CD144 magnetic bead sorting, ≈70% CD144+ cells and 30% CD144- cells were obtained. On the basis of single-cell RNA sequencing data, the CD144+ cells and CD144- cells were found to be highly similar to primary heart valve endothelial cells and primary heart valve interstitial cells in gene expression profile. Furthermore, CD144+ cells had the typical function of primary heart valve endothelial cells, including tube formation, uptake of low-density lipoprotein, generation of endothelial nitric oxide synthase, and response to shear stress. Meanwhile, CD144- cells could secret collagen and matrix metalloproteinases, and differentiate into osteogenic or adipogenic lineages like primary heart valve interstitial cells. Therefore, we identified CD144+ cells and CD144- cells as hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells, respectively. Using single-cell RNA sequencing analysis, we demonstrated that the trajectory of heart valve cell differentiation was consistent with embryonic valve development. We identified the main switch genes (NOTCH1, HEY1, and MEF2C), signaling pathways (TGF-β, Wnt, and NOTCH), and transcription factors (MSX1, SP5, and MECOM) that mediated the differentiation. Finally, we found that hiPSC-derived valve interstitial-like cells might derive from hiPSC-derived valve endothelial-like cells undergoing endocardial-mesenchymal transition. CONCLUSIONS: In summary, this is the first study to report an efficient strategy to generate functional hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells from hiPSCs, as well as to elucidate the differentiation trajectory and transcriptional dynamics of hiPSCs differentiated into heart valve cells.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Cai Z, Zhu M, Xu L, et al. Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells. Circulation. 2024. PMID: 38357822. doi:10.1161/CIRCULATIONAHA.123.065143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。